<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-0FHVXCVY</identifier><date>2024</date><creator>Škrbinc, Breda</creator><relation>documents/doc/0/URN_NBN_SI_doc-0FHVXCVY_001.pdf</relation><relation>documents/doc/0/URN_NBN_SI_doc-0FHVXCVY_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 48-52</format><identifier identifier_type="COBISSID_HOST">203894531</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-0FHVXCVY</identifier><language>slv</language><publisher publisher_location="Ljubljana">Institute of Oncology</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><source>Sodobna dognanja</source><rights>InC</rights><subject language_type_id="slv">ginekološki raki</subject><subject language_type_id="slv">onkološko zdravljenje</subject><subject language_type_id="slv">raki rodil</subject><title>Immunotherapy in cervical cancer</title><title>Imunoterapija pri raku materničnega vratu</title></Record>